Pictured: Hands exchanging money for medical science objects/Taylor Tieden for BioSpace
Things are starting to look up for venture capital investment in biopharmaceuticals in the early part of 2024 following a post-pandemic slump. Following a 19% year-on-year decline in overall deal value in Q4 2023,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
